News Column

New Cancer Gene Therapy Study Findings Reported from University of California (Chemotherapy in the treatment of metastatic, persistent, and recurrent...

August 18, 2014



New Cancer Gene Therapy Study Findings Reported from University of California (Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer)

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Investigators discuss new findings in Biotechnology. According to news reporting originating from Orange, California, by NewsRx correspondents, research stated, "Patients with cervical cancer represent a vulnerable population with limited chemotherapeutic options. This year, two large trials focusing on detection/screening and treatment of advanced stage cervical cancer were featured in the opening plenary session of the American Society of Clinical Oncology Annual Meeting."

Our news editors obtained a quote from the research from the University of California, "As such, a review of the evolution of chemotherapy in the treatment of this disease is warranted. Following the establishment of cisplatin as an effective single-agent regimen in patients with advanced stage, recurrent, or persistent cervical cancer, several platinum-containing combinations were studied. Ultimately, the adoption of cisplatin chemosensitizing radiation resulted in relative 'cisplatin resistance' and the concept of nonplatinum doublets emerged as an active area of investigation."

According to the news editors, the research concluded: "In an era of biologics, combined therapy with cytotoxic drugs and molecular targeted agents, as well as the use of nonplatinum doublets, represent an exciting area yet to be fully explored."

For more information on this research see: Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer. Current Opinion in Obstetrics & Gynecology, 2014;26(4):314-321. Current Opinion in Obstetrics & Gynecology can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA. (Lippincott Williams and Wilkins - www.lww.com; Current Opinion in Obstetrics & Gynecology - journals.lww.com/co-obgyn/pages/default.aspx)

The news editors report that additional information may be obtained by contacting R.N. Eskander, University of California, Irvine Med Center, Orange, CA 92668, United States (see also Biotechnology).

Keywords for this news article include: Antineoplastics, Biotechnology, Pharmaceuticals, Drugs, Orange, Oncology, Cisplatin, California, Chemotherapy, United States, Alkylating Agents, Cancer Gene Therapy, North and Central America

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Cancer Gene Therapy Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters